Tau as a Potential Novel Therapeutic Target in Ischemic Stroke

被引:30
|
作者
Zheng, Guo-Qing [1 ]
Wang, Xiu-Min [1 ]
Wang, Yan [1 ]
Wang, Xiao-Tong [1 ]
机构
[1] Second Affiliated Hosp, Wenzhou Med Coll, Ctr Neurol & Rehabil, Wenzhou 325027, Peoples R China
关键词
TAU PROTEINS; ISCHEMIC STROKE; THERAPEUTIC TARGET; CEREBRAL-ISCHEMIA; HUMAN BRAIN; PHOSPHORYLATION; RAT; HYPERPHOSPHORYLATION; REPERFUSION; DEPHOSPHORYLATION; OLIGODENDROCYTES; IMMUNOREACTIVITY; HIPPOCAMPUS;
D O I
10.1002/jcb.22408
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stroke is associated with high mortality and major disability burdens worldwide, but there are few effective and widely available therapies. Tau plays an important role in promoting microtubule assembly and stabilizing microtubule networks with phosphorylation regulating these functions. Based on the "ischemic-reperfusion theory" of Alzheimer's disease, some previous studies have focused on the relationship of tau and Alzheimer lesions in experimental brain ischemia. Thus, we hypothesize that the alterations in phosphorylation of tau are critical to microtubule dynamics and metabolism, and contribute to the pathophysiologic mechanisms during brain ischemia and/or reperfusion processes. We infer that regulation of phosphorylation of tau may be considered as a potential new therapeutic target in ischemic stroke. J. Cell. Biochem. 109: 26-29, 2010. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:26 / 29
页数:4
相关论文
共 50 条
  • [1] Tau as a potential therapeutic target for ischemic stroke
    Chen, Xin
    Jiang, Hua
    AGING-US, 2019, 11 (24): : 12827 - 12843
  • [2] AMPK: Potential Therapeutic Target for Ischemic Stroke
    Jiang, Shuai
    Li, Tian
    Ji, Ting
    Yi, Wei
    Yang, Zhi
    Wang, Simeng
    Yang, Yang
    Gu, Chunhu
    THERANOSTICS, 2018, 8 (16): : 4535 - 4551
  • [3] Osteopontin as a Potential Therapeutic Target for Ischemic Stroke
    Zhu, Qiquan
    Luo, Xu
    Zhang, Jie
    Liu, Yun
    Luo, Hansheng
    Huang, Qin
    Cheng, Yuan
    Xie, Zongyi
    CURRENT DRUG DELIVERY, 2017, 14 (06) : 766 - 772
  • [4] Purinergic signaling: a potential therapeutic target for ischemic stroke
    Lu Wang
    Ying-Jie Li
    Xu Yang
    Bo Yang
    Xin Zhang
    Jing Zhang
    Qi Zhang
    Xu-Dong Cheng
    Jian-Hong Wang
    Neng-Wei Yu
    Purinergic Signalling, 2023, 19 : 173 - 183
  • [5] δ-Opioid receptor as a potential therapeutic target for ischemic stroke
    Kalpana Subedi
    Hongmin Wang
    NeuralRegenerationResearch, 2020, 15 (01) : 20 - 24
  • [6] Mitochondrial Dynamics: A Potential Therapeutic Target for Ischemic Stroke
    Zhou, Xiangyue
    Chen, Hanmin
    Wang, Ling
    Lenahan, Cameron
    Lian, Lifei
    Ou, Yibo
    He, Yue
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [7] δ-Opioid receptor as a potential therapeutic target for ischemic stroke
    Subedi, Kalpana
    Wang, Hongmin
    NEURAL REGENERATION RESEARCH, 2020, 15 (01) : 20 - 24
  • [8] Purinergic signaling: a potential therapeutic target for ischemic stroke
    Wang, Lu
    Li, Ying-Jie
    Yang, Xu
    Yang, Bo
    Zhang, Xin
    Zhang, Jing
    Zhang, Qi
    Cheng, Xu-Dong
    Wang, Jian-Hong
    Yu, Neng-Wei
    PURINERGIC SIGNALLING, 2023, 19 (01) : 173 - 183
  • [9] Glutamate excitotoxicity: Potential therapeutic target for ischemic stroke
    Shen, Zihuan
    Xiang, Mi
    Chen, Chen
    Ding, Fan
    Wang, Yuling
    Shang, Chang
    Xin, Laiyun
    Zhang, Yang
    Cui, Xiangning
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 151
  • [10] Glycolytic reprogramming in microglia: A potential therapeutic target for ischemic stroke
    Zhang, Guangming
    Zhao, Anliu
    Zhang, Xiaolu
    Zeng, Miao
    Wei, Huayuan
    Yan, Xu
    Wang, Jie
    Jiang, Xijuan
    Dai, Yongna
    CELLULAR SIGNALLING, 2024, 124